DiagnaMed Holdings Corp. · CSE:DMED
DiagnaMed — Investor Presentation (January 2025)
17 slides from DiagnaMed's investor presentation, January 2025
Slide 1: DiagnaMed Corporate Presentation
DiagnaMed Corporate Presentation January 2025 CSE: DMED | OTCQB: DGNMF
Slide 2: Forward-Looking Statements
Forward-Looking Statements This presentation of DiagnaMed Holdings Corp. (“DiagnaMed”) contains "forward-looking information", which may include, but is not limited to, statements with respect to anticipated business plans or strategies of DiagnaMed, the anticipated date of completion of product dev
Slide 3: About Us
About Us Technology Solutions for Cleantech and Life Sciences Hydrogen Artificial Intelligence Hydrogen from AI Diagnostics and petroleum reservoirs Drug Discovery and natural hydrogen fields DiagnaMed CSE: DMED | OTCQB: DGNMF
Slide 4: Hydrogen Production
Hydrogen Production DiagnaMed CSE: DMED | OTCQB: DGNMF
Slide 5: Global Hydrogen Market
Global Hydrogen Market Projected to grow from USD 262.13 billion in 2024 to USD 556.56 billion by 2034 DiagnaMed Precedence Research: Hydrogen Market Size, Share and Trends 2024 to 2034. Accessed January 2, 2025. CSE: DMED | OTCQB: DGNMF
Slide 6: The HOPE Process
The HOPE Process Produces hydrogen directly from petroleum reservoirs and natural hydrogen fields Proprietary production process using Electromagnetic wave heating Grid (Patent Pending WO2023044149A1) Potential to produce a low-carbon clean hydrogen with production cost as low as $0.86/kg (Report: A
Slide 7: Technology Validation
Technology Validation Developed by Dr. Qingwang Yuan of The HOPE Group at Texas Tech University DiagnaMed https://www.thehopegroup.tech/ CSE: DMED | OTCQB: DGNMF
Slide 8: Our Opportunity
Our Opportunity We enable petroleum & natural hydrogen companies to unlock potential, reducing greenhouse gas emissions, and delivering cost-effective, carbon-zero hydrogen Transforming over 25,000 active oil and gas fields Repurposing 2-3 million abandoned wells in the United States Stimulating geo
Slide 9: Our Partners
Our Partners CSE: QIMC The HOPE Group, led Exploration Electromagnetic Heating by Dr. Qingwang Yuan collaboration Collaboration Ongoing discussions with petroleum companies and natural hydrogen explorers DiagnaMed CSE: DMED | OTCQB: DGNMF
Slide 10: AI Diagnostics & Drug Repurposing
AI Diagnostics & Drug Repurposing DiagnaMed CSE: DMED | OTCQB: DGNMF
Slide 11: AI Diagnostics
AI Diagnostics B R A I N A G E A I ® Estimating BR AIN AGE® Providing Brain Health Risk Score Monitoring Overall Brain Health DiagnaMed CSE: DMED | OTCQB: DGNMF
Slide 12: AI Drug Repurposing
AI Drug Repurposing Focus on new drug discovery and drug repurposing for brain health conditions such as mental health and neurological disorders DiagnaMed CSE: DMED | OTCQB: DGNMF
Slide 13: Our Growth Plan
Our Growth Plan BR A IN AGE® Development of Novel Therapeutics using AI Unlock new uses of Focus on mental health and BR AIN AGE® AI neurological disorders Clinical diagnostic tool for monitoring and screening of mental health, Establish BR AIN AGE® AI neurological and brain injuries provider networ
Slide 14: Our Partners
Our Partners DiagnaMed CSE: DMED | OTCQB: DGNMF
Slide 15: Team
Team Experienced in capital raising, product development and commercialization for life sciences, natural resources and cleantech sectors Fabio Chianelli Jing Peng, CPA John Karagiannidis Special Advisor, Natural Hydrogen Chairman and CEO Chief Financial Officer Current and Past Current and Past Cur
Slide 16: Financial Snapshot
Financial Snapshot 81,408,640 Common Shares outstanding 1,500,000 4,500,000 @ $0.10, expire Jan 4, 2027 @ $0.05, expire Nov 13, 2029 Stock Options ~ 20% Insider Ownership DiagnaMed CSE: DMED | OTCQB: DGNMF
Slide 17: Thank You
THANK YOU DiagnaMed Holdings Corp. 82 Richmond Street East Toronto, ON M5C 1P1 t. 416-800-2684 e. info@diagnamed.com w. diagnamed.com DiagnaMed CSE: DMED | OTCQB: DGNMF
DiagnaMed Holdings — Investor Presentation (January 2025) on 6ix